Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Heptares Hits Novartis Milestone

January 25, 2011 6:55 am | News | Comments

Heptares Therapeutics Ltd, a drug discovery company targeting G-protein-coupled receptors, announced that it has successfully generated a stabilised receptor (StaR) to a GPCR target nominated by Novartis using its proprietary StaR technology.


ACT Releases Telatinib Data

January 25, 2011 6:49 am | News | Comments

ACT Biotech, Inc. released data on additional analysis of the Phase 2 clinical trial of telatinib in patients with metastatic stomach cancer that further supports the highly-potent nature of the antiangiogenic agent.


QRxPharma Begins MoxDuo Trial

January 25, 2011 6:46 am | News | Comments

QRxPharma Limited has initiated a Phase 3 trial (Study 022) to compare the tolerability and safety profile of MoxDuo IR to equi-analgesic doses of either morphine or oxycodone given alone.


Mylan Settles Lipitor Suit

January 25, 2011 6:38 am | News | Comments

Mylan Inc. said it settled a lawsuit with Pfizer Inc. over the blockbuster cholesterol drug Lipitor, but terms of the settlement are confidential. The settlement deal is subject to review by the Justice Department and Federal Trade Commission.


Abbott to Report 4th Quarter Earnings

January 25, 2011 6:34 am | News | Comments

Abbott Laboratories will report its fourth-quarter and full-year results on Wednesday before the market opens. Wall Street analysts will be watching for Abbott's 2011 earnings guidance, with particular focus on sales of the company's best-selling product Humira.


Mylan Selling Generic Protonix

January 25, 2011 6:31 am | News | Comments

Mylan Inc. said it is now shipping a generic version of Pfizer Inc.'s heartburn drug Protonix. One of the key patents supporting Protonix expired Wednesday, and Mylan said it received final approval from the Food and Drug Administration.


New Measures to Fight Medicare Fraud

January 25, 2011 6:27 am | by Kelli Kennedy | News | Comments

Federal health officials announced new security measures to combat Medicare fraud, including tougher screenings for providers and the ability to withhold payments during investigations.


Lilly Oncology VP Out

January 25, 2011 6:20 am | News | Comments

Eli Lilly and Company announced that John H. Johnson, senior vice president and president of Lilly Oncology, has resigned effective January 28, 2011. A successor will be announced in the coming weeks.


J & J Bottom Line Hit By Recalls

January 25, 2011 6:18 am | News | Comments

Health care giant Johnson & Johnson, hammered by numerous recalls that have kept some popular nonprescription medicines and other products off the market, posted a 12 percent profit decline and a 5.5 percent drop in revenue for the fourth quarter.


Liquid Handling Robot

January 24, 2011 7:35 am | Product Releases | Comments

Hamilton Robotics has integrated Peak Robotics' KiNEDx robot series with Hamilton's MICROLAB STAR automated liquid handling workstation. The KiNEDx 4- and 5-axis robots increase the STAR's access to microplate samples and third-party devices.


Clone Screening

January 24, 2011 7:12 am | Product Releases | Comments

Genetix announced the launch of its ClonePix 2 system – the second generation system based on the company’s well-established and successful technology and chemistries for clone screening and selection.


Gene Sequencing Not Sufficient in Disease Modeling

January 24, 2011 7:08 am | News | Comments

Despite what you might have heard, genetic sequencing alone is not enough to understand human disease. Researchers have shown that functional tests are absolutely necessary to understand the biological relevance of the results of sequencing studies.


HIV Finding May Lead to New Drugs

January 24, 2011 6:58 am | News | Comments

HIV adapts in a surprising way to survive and thrive in its hiding spot within the human immune system, scientists have learned. While the finding helps explain why HIV remains, it also offers researchers a new, unexpected way to try to stop the virus.


PerkinElmer Adds Sequencing Service

January 24, 2011 6:55 am | News | Comments

PerkinElmer, Inc. announced the launch of a next generation DNA sequencing and data analysis services for genome sequencing at the company's lab in Branford, Conn.


Teva Signs $1.5B Credit Facility

January 24, 2011 6:49 am | News | Comments

Drug developer Teva Pharmaceutical Industries Ltd. said it signed a new three-year, $1.5 billion credit facility. The company said the new facility is part of its strategy to secure liquidity for future business needs through revolving credit lines.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.